Notice:The Detection Kit for 2019 Novel Coronavirus (2019-nCoV) RNA (PCR-Fluorescence Probing)”) product was included in the World Health Organization emergency use list on May 14, 2020, and can be purchased from other countries and regions. If there is no special Circumstances, the available purchase period of the product is 1 year.
Catalog Number: DA0930~DA0932
2019 Novel Coronavirus (2019-nCoV) RNA detection kit(PCRFluorescence probing) is used for the in vitro qualitative detection of novel coronavirus (2019-nCoV) ORF1ab and N gene in the throat swabs, sputum ,nasopharygeanl swab specimens of suspected pneumonia patients infected by novel coronavirus, suspected clustering cases and others needing diagnosis or differential diagnosis for novel coronavirus.
Certificates for kits：
Da An Gene’s 2019 Novel Coronavirus (2019-nCoV) RNA detection kit (PCR Fluorescence probing) has been approved by CE-IVD, NMPA and NADFC. And it was used in many hospitals from EU & Asia & America & Others and got high reputation.
Simulated virus to ensure quality：
The positive control and negative control of the kit are simulated RNA virus particles, which are similar to the virus structure, and they are coated with protein as well, join the extraction step parallelly, which iseasier to monitor the entire experimental process and ensure the reliability ofthe test results.
For the definitions of "suspected cases" and "suspected clustering cases", refer to the documents (current versions) such as Diagnosis and Treatment Scheme for Pneumonia Patients Infected by Novel Coronavirus and Monitoring Scheme for Pneumonia Patients Infected by Novel Coronavirus issued by the Chinese Center for Disease Control andPrevention (China CDC).
This product is only used for the auxiliary diagnosis and in vitro diagnosis (IVD) of pneumonia infected by novel coronavirus (2019-nCoV) since december 2019 under emergency. Instead, it cannot be clinically used as a general IVD reagent. In use, the relevant requirements of the documents such as Diagnosis and Treatment Scheme for Pneumonia Patients Infected by NovelCoronavirus and Monitoring Scheme for Pneumonia Patients Infected by NovelCoronavirus shall be followed.
Detection of novel coronavirus RNA shall meet the requirements of Technical Guideline of the China CDC for Laboratory Detection of New Coronavirus Pneumonia and other documents, so as to carry out the regulations on biosafety. The detection results of this kit are for clinical reference only and should not be used as the sole criteria for clinical diagnosis. It is recommended to conduct a comprehensive analysis on the condition in combination with the clinical manifestations of the patient and other laboratory tests.
2019 novel corona virus (2019-nCOV) RNA detection kit